So let me get this straight.
Clinical trial results are due this month (after months of delays).
CEO has been appointed - 3 March 2022 & the unlisted options have an exercise price of 8/12/16c respectively.
Merchant Funds Management on the register.
Exclusive worldwide license - Dolce Cann Global (<0.3%) THC
Always had conviction here, nothing has changed. Bought more today.
So let me get this straight. Clinical trial results are due this...
Add NTI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $92.58M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 86 | 9.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.2¢ | 6584 | 3 |
View Market Depth
| Last trade - 16.12pm 03/05/2024 (20 minute delay) ? |
| NTI (ASX) Chart |
Day chart unavailable